​​Pyridoxine 50 mg tabs/PAC-10x10​

General description
Pyridoxine 50 mg tablets, 10 blisters of 10 tablets each

Technical specifications:
Pyridoxine (hydrochloride) 50 mg tablets, 10 blisters of 10 tablets each
complying with one of the pharmacopeias:
BP
Ph.Eur.
Ph.Int.
USP
The tablets should comply with one of the pharmacopeias:
Ph.Eur , BP, Ph. Int, USP general monograph for tablets and general notices

Guidelines for use (labelling information):
It is used to treat low level of Vitamin B6 in the body and in the treatment of a condition called idiopathic sideroblastic anaemia where the red cells in the blood do not form properly.
Pyridoxine is recommended in HIV patients on isoniazid as it is a benign intervention which prevents peripheral neuropathy and other isoniazid toxicities.
The dosing of pyridoxine when administered with isoniazid preventive therapy for HIV-infected individuals is 25- 50mg daily.

Reference:
For general information on uses, contra-indications, precautions, dose, and adverse effects of this product, please refer to the WHO Model Formulary:

Shelf life:
36 months at ICH zone IVa (30 +/- 2 C, 65% +/-5% RH)

Packaging and Labeling:
Tablets packed in blister of PVC/Alu or Alu/Alu 100, protected from light and moisture.